These findings not only substantiate the critical role of NS3 in developing cancer, but also suggest that strategies to increase PPM1A expression or activity in cancer cells could be explored as a therapeutic strategy for HCC prevention and treatment. The gene discussed is KRAS; the disease is hepatocellular carcinoma.